For decades, the pharmaceutical manufacturing industry has wrestled with the complications of paper-based compliance. Not only is this system cumbersome and inefficient, but the margin for error it presents is also considerably high. With the ever-watchful eye of the FDA auditing these paper records, any missteps can lead to costly warnings, making drug production a ... Read more